Published On: July 12th, 2010
The resolution to the Avandia brouhaha will be seen as an indicator of how the FDA’s new leadership handles safety concerns about drugs that are already on the market.

Read the original here:
Avandia, Qnexa Mean a Big Week for FDA Advisory Committee
Loading...
Leave a comment



Did you know:




